GlassScriptPhysician profile
Scott C Ulmer
NPI 1063441772
$27,836.56
in general payments reported to CMS, 2019-2025
55 companies · $2,146 in 2025
The $2,146 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $1,432 · 2021: $3,876 · 2022: $9,168 · 2023: $4,832 · 2024: $5,813 · 2025: $2,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,353 · Food and Beverage: $4,740 · Travel and Lodging: $494 · Education: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,352.50 |
| Food and Beverage | $4,740.23 |
| Travel and Lodging | $494.40 |
| Education | $203.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $4,050.82 | 2021-2025 | Blenrep, Ojjaara |
| Gilead Sciences, INC. | $3,936.55 | 2021-2025 | Trodelvy |
| Astrazeneca Pharmaceuticals LP | $3,183.46 | 2022-2024 | Calquence, Enhertu |
| Karyopharm Therapeutics INC. | $2,675.47 | 2024 | Xpovio |
| Kite Pharma, INC. | $2,414.28 | 2020-2021 | |
| Genmab U.S., INC. | $1,933.51 | 2023-2025 | Epkinly |
| Genzyme Corporation | $1,641.32 | 2022-2025 | |
| Athenex Pharmaceutical Division, LLC | $1,250.00 | 2020 | |
| Adaptive Biotechnologies Corporation | $831.34 | 2021-2025 | Clonoseq |
| Varian Medical Systems, INC. | $750.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $483.04 | 2019-2025 | Opdualag, Krazati |
| Novartis Pharmaceuticals Corporation | $464.77 | 2019-2025 | |
| Genentech USA, INC. | $458.32 | 2019-2025 | Lunsumio, Columvi, Polivy |
| Janssen Biotech, INC. | $387.63 | 2022-2025 | Tecvayli, Darzalex, Carvykti |
| Siemens Medical Solutions USA, INC. | $375.00 | 2021 |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Ulmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.